Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Non-cash Items: 2020-2024

Historic Non-cash Items for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to $11.2 million.

  • Tango Therapeutics' Non-cash Items rose 82.49% to $59.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.8 million, marking a year-over-year increase of 82.49%. This contributed to the annual value of $11.2 million for FY2024, which is 42.06% up from last year.
  • As of FY2024, Tango Therapeutics' Non-cash Items stood at $11.2 million, which was up 42.06% from $7.9 million recorded in FY2023.
  • Tango Therapeutics' Non-cash Items' 5-year high stood at $51.4 billion during FY2021, with a 5-year trough of $4.7 million in FY2022.
  • For the 3-year period, Tango Therapeutics' Non-cash Items averaged around $7.9 million, with its median value being $7.9 million (2023).
  • In the last 5 years, Tango Therapeutics' Non-cash Items spiked by 674.84% in 2021 and then slumped by 99.99% in 2022.
  • Tango Therapeutics' Non-cash Items (Yearly) stood at $6.6 billion in 2020, then soared by 674.84% to $51.4 billion in 2021, then slumped by 99.99% to $4.7 million in 2022, then spiked by 68.42% to $7.9 million in 2023, then soared by 42.06% to $11.2 million in 2024.